LeadIQ logo
Learn more at LeadIQ.com

Insights

Loading spinner
Gathering insights about Immunovant…

Immunovant Tech Stack

Immunovant uses 8 technology products and services including cdnjs, Microsoft Outlook, Twitter Emoji (Twemoji), and more. Explore Immunovant's tech stack below.

  • cdnjs
    Content Delivery Network
  • Microsoft Outlook
    Email
  • Twitter Emoji (Twemoji)
    Font Scripts
  • Moment.js
    Javascript Libraries
  • Smartsheet
    Project Management
  • Adobe Acrobat DC
    Rich Text Editors
  • HSTS
    Security
  • Adobe Creative Suite
    Visualisation Software

Media & News

Immunovant's Email Address Formats

Immunovant uses at least 1 format(s):
Immunovant Email FormatsExamplePercentage
First.Last@immunovant.comJohn.Doe@immunovant.com
90%
Last.First@immunovant.comDoe.John@immunovant.com
8%
First.Middle@immunovant.comJohn.Michael@immunovant.com
1%
Last@immunovant.comDoe@immunovant.com
1%

Frequently Asked Questions

Where is Immunovant's headquarters located?

Minus sign iconPlus sign iconImmunovant's main headquarters is located at 320 W 37th St New York, 10018 US. The company has employees across 4 continents, including North AmericaEuropeSouth America.

What is Immunovant's stock symbol?

Minus sign iconPlus sign iconImmunovant is a publicly traded company; the company's stock symbol is IMVT.

What is Immunovant's official website and social media links?

Minus sign iconPlus sign iconImmunovant's official website is immunovant.com and has social profiles on LinkedIn.

How much revenue does Immunovant generate?

Minus sign iconPlus sign icon As of November 2024, Immunovant's annual revenue reached $75M.

What is Immunovant's SIC code NAICS code?

Minus sign iconPlus sign iconImmunovant's SIC code is 8733 - Noncommercial Research Organizations NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Immunovant have currently?

Minus sign iconPlus sign iconAs of November 2024, Immunovant has approximately 331 employees across 4 continents, including North AmericaEuropeSouth America. Key team members include Chief Technology Officer: J. S.Chief Operating Officer: M. G.Chief Legal Officer And Corporate Secretary: M. L.. Explore Immunovant's employee directory with LeadIQ.

What industry does Immunovant belong to?

Minus sign iconPlus sign iconImmunovant operates in the Biotechnology Research industry.

What technology does Immunovant use?

Minus sign iconPlus sign iconImmunovant's tech stack includes cdnjsMicrosoft OutlookTwitter Emoji (Twemoji)Moment.jsSmartsheetAdobe Acrobat DCHSTSAdobe Creative Suite.

What is Immunovant's email format?

Minus sign iconPlus sign iconImmunovant's email format typically follows the pattern of . Find more Immunovant email formats with LeadIQ.

How much funding has Immunovant raised to date?

Minus sign iconPlus sign icon As of November 2024, Immunovant has raised $450M in funding. The last funding round occurred on Sep 27, 2023 for $450M.

When was Immunovant founded?

Minus sign iconPlus sign iconImmunovant was founded in 2018.
Immunovant

Immunovant

Biotechnology ResearchNew York, United States201-500 Employees

Immunovant, Inc. is a clinical-stage immunology company dedicated to enabling normal lives for people with autoimmune diseases. As a trailblazer in anti-FcRn technology, the Company is developing innovative, targeted therapies to meet the complex and variable needs of people with autoimmune diseases. For additional information on the Company, please visit immunovant.com.

For U.S. residents only.

Section iconCompany Overview

Headquarters
320 W 37th St New York, 10018 US
Website
immunovant.com
SIC Code
8733 - Noncommercial Research Organizations
Stock Symbol
IMVT
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2018
Employees
201-500

Section iconMedia & News

Section iconFunding & Financials

  • $450M

    Immunovant has raised a total of $450M of funding over 4 rounds. Their latest funding round was raised on Sep 27, 2023 in the amount of $450M.

  • $50M$100M

    Immunovant's revenue is in the range of $50M$100M

Section iconFunding & Financials

  • $450M

    Immunovant has raised a total of $450M of funding over 4 rounds. Their latest funding round was raised on Sep 27, 2023 in the amount of $450M.

  • $50M$100M

    Immunovant's revenue is in the range of $50M$100M

Company Leadership

  • Stylized image of a person
    J. S.
    Chief Technology Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    M. G.
    Chief Operating Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    M. L.
    Chief Legal Officer And Corporate Secretary
    Phone icon
    Mobile Phone
  • Stylized image of a person
    R. B.
    Chief Financial Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    J. G. B.
    Chief Development Officer (cdo)
    Phone icon
    Mobile Phone

Employee Directory

  • Stylized image of a person
    R. B.
    Chief Financial Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    J. G. B.
    Chief Development Officer (cdo)
    Phone icon
    Mobile Phone
  • Stylized image of a person
    P. S.
    Ceo
    Phone icon
    Mobile Phone
  • Stylized image of a person
    B. M.
    Chief Medical Officer
    Phone icon
    Mobile Phone
  • Stylized image of a person
    F. T.
    Executive Chairman
    Phone icon
    Mobile Phone

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust LeadIQ to help them build pipeline confidently.

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.